Waarom Leefbaar Rotterdam het heeft afgelegd tegen links en hoe een ‘bizar experiment’ leidde tot een klassieke middencoalitie met tien wethouders: lees het in deze longread-reconstructie. nrc.nl/nieuws/2018/06…

Getting ready for an action packed IBCN Annual Meeting in Rotterdam, Netherlands, from October 11th-13th, 2018! Advancing #bladdercancer research with internationally renowned experts. IBCN

We are thrilled to host #IBCN’s annual meeting in #Rotterdam next week. World’s top scientists in #bladder cancer research. Our city will look stunning with the Indian Summer coming this week! Cc Stephen B. Williams, MD, MBA, MS, FACHE Petros Grivas Ashish M. Kamat, MD, MBBS Peter Black

We are looking for a bioinformatician for projects on genomics in metastatic #bladder cancer and upper tract #urothelial carcinoma werkenbijerasmusmc.nl/en/vacancy/230…

Precision Medicine in #BladderCancer: Updates from Dr. Dan Theodorescu of Cedars-Sinai and Dr. Florus C. de Jong & Dr. Tahlita C.M. Zuiverloon of Erasmus MC ow.ly/8gCu50uytgm #cancerawareness

On our way to Billund! Looking out for a great IBCN meeting in #Aarhus #momu with Tahlita Zuiverloon MD PhD Joep J. de Jong IBCN Blaaskankercentrum

12 Early Stage Researcher/PhD student positions in Digital Pathology available in CLARIFY project euraxess.ec.europa.eu/jobs/469494 #MSCA #MSCAjobalert #ResearchImpactEU #H2020 #ESR

Conclusions and considerations of Assoc. Prof. @joostboormans's lecture "PD-1/PD-L1 Inhibitors are replacing perioperative chemotherapy" #EAU20

Hoe onze afweer worstelt met corona. De een wordt erg ziek, de ander merkt haast niets. Wat weten we ervan ? Het antwoord hangt af van welk soort wetenschapper je het vraagt. nrc.nl/nieuws/2020/10…

Measuring #SARSCoV2 in urine, stool and semen to identify new #COVID19 clusters! The Dutch RIVM shows us how to do it. Read more Urologic Oncology Tahlita Zuiverloon MD PhD ErasmusMC.Urology.Research Joep J. de Jong Blaaskankercentrum Pim van den Dool

Value based health care financing project zonmw toegekend aan Bangma voor Anser en Reinier de Graaf prostaat netwerken.

Just received a stealth message that deserves some attention - congratulations to @joostboormans for assuming the reins of Dept Urology Erasmus MC ErasmusMC.Urology.Research in Rotterdam - a renowned institution, with big shoes to fill (chris bangma), but no one more suited! #bladdercancer

Open Access Article from the March 2021 Issue: T1 Substaging of Nonmuscle Invasive #BladderCancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis Read the full text here: bit.ly/32OZzzS Christiaan de Jong

Handen af van onze hulpdiensten. Hoop dat de relschoppers vandaag nog in kraag worden gepakt en schade tot laatste eurocent wordt verhaald.

Great work from our international collaboration: Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical BCG medrxiv.org/content/10.110… Christiaan de Jong Dan Theodorescu Tahlita Zuiverloon MD PhD @joostboormans Emiel Janssen Ellen Zwarthoff Teemu Daniel Laajala

The IMPASSE study amazingerasmusmc.nl/urologie/erasm… will investigate if our previously developed BCG Response Subtypes medrxiv.org/content/10.110… can be prospectively validated, and determines if targeted therapies using PDx tumoroid models are feasible. Blaaskankercentrum Tahlita Zuiverloon MD PhD Christiaan de Jong

With a relatively simple test, urologist may accurately determine in the future which patients will benefit from BCG bladder instillations. In 30/50% percent of patients, treatment is not successful, while treatment duration is lengthy and unpleaseant. amazingerasmusmc.com/oncology/pcr-t…

Here it is! After years of hard labour we finally have our paper published in Science Translational Medicine. Very proud! Hopefully it will form a basis for optimized risk stratification and BCG treatment of bladder cancer patients Blaaskankercentrum @joostboormans science.org/doi/10.1126/sc…

Mutational burden, infiltrating t-cells, Molecular subtypes, and now stroma-derived TGF-β. The plot thickens for checkpoint inhibitor response in #bladdercancer #MIBC nature.com/articles/natur…

From our co-Editor in Chief, Dan Theodorescu : Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines content.iospress.com/articles/bladd…